Catherine Feeney

1.9k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Catherine Feeney is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Catherine Feeney has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Clinical Biochemistry and 4 papers in Physiology. Recurrent topics in Catherine Feeney's work include Mitochondrial Function and Pathology (12 papers), Metabolism and Genetic Disorders (12 papers) and ATP Synthase and ATPases Research (3 papers). Catherine Feeney is often cited by papers focused on Mitochondrial Function and Pathology (12 papers), Metabolism and Genetic Disorders (12 papers) and ATP Synthase and ATPases Research (3 papers). Catherine Feeney collaborates with scholars based in United Kingdom, United States and Australia. Catherine Feeney's co-authors include Robert McFarland, Douglass M. Turnbull, Robert W. Taylor, Gráinne S. Gorman, Yi Shiau Ng, Andrew M. Schaefer, Charlotte L. Alston, Emma L. Blakely, Rita Horváth and Patrick Yu‐Wai‐Man and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Catherine Feeney

15 papers receiving 1.1k citations

Hit Papers

Prevalence of nuclear and mitochondrial DNA mutations rel... 2015 2026 2018 2022 2015 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease
    2015 643 citations Gráinne S. Gorman, Andrew M. Schaefer et al. Annals of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Feeney United Kingdom 7 1.0k 599 114 111 85 16 1.1k
Helen Tuppen United Kingdom 20 1.5k 1.5× 721 1.2× 159 1.4× 125 1.1× 114 1.3× 34 1.7k
L. He United Kingdom 9 665 0.7× 374 0.6× 127 1.1× 55 0.5× 70 0.8× 10 751
Jyrki Kaukonen Finland 6 1.1k 1.1× 655 1.1× 234 2.1× 144 1.3× 56 0.7× 7 1.2k
M L Savontaus Finland 15 1.2k 1.2× 495 0.8× 218 1.9× 158 1.4× 72 0.8× 18 1.4k
Chun Shi Lin United States 8 825 0.8× 237 0.4× 81 0.7× 145 1.3× 216 2.5× 8 1.1k
Petri Luoma Finland 8 926 0.9× 526 0.9× 350 3.1× 113 1.0× 69 0.8× 8 1.1k
Jirair K. Bedoyan United States 20 516 0.5× 250 0.4× 39 0.3× 220 2.0× 199 2.3× 48 996
Paul J.M. Savelkoul Netherlands 15 729 0.7× 136 0.2× 45 0.4× 46 0.4× 121 1.4× 21 951
M. Pineda Spain 13 285 0.3× 127 0.2× 111 1.0× 118 1.1× 67 0.8× 26 533
Zarazuela Zolkipli‐Cunningham United States 14 406 0.4× 232 0.4× 64 0.6× 79 0.7× 51 0.6× 25 566

Countries citing papers authored by Catherine Feeney

Since Specialization
Citations

This map shows the geographic impact of Catherine Feeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Feeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Feeney more than expected).

Fields of papers citing papers by Catherine Feeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Feeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Feeney. The network helps show where Catherine Feeney may publish in the future.

Co-authorship network of co-authors of Catherine Feeney

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Feeney. A scholar is included among the top collaborators of Catherine Feeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Feeney. Catherine Feeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hollingsworth, Kieren G., Arthur G. Pratt, Andrew J. Degnan, et al.. (2025). Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (RAMUS): a single-arm, experimental medicine study. The Lancet Rheumatology. 8(1). e42–e52.
2.
McFarland, Robert, Louise Hyslop, Catherine Feeney, et al.. (2025). Mitochondrial Donation in a Reproductive Care Pathway for mtDNA Disease. New England Journal of Medicine. 393(5). 461–468. 5 indexed citations
3.
4.
Thomas, Rhys H., Amy Hunter, Catherine Feeney, et al.. (2022). Research priorities for mitochondrial disorders: Current landscape and patient and professional views. Journal of Inherited Metabolic Disease. 45(4). 796–803. 6 indexed citations
5.
Houghton, David, Yi Shiau Ng, Matthew Jackson, et al.. (2022). Phase II Feasibility Study of the Efficacy, Tolerability, and Impact on the Gut Microbiome of a Low-Residue (Fiber) Diet in Adult Patients With Mitochondrial Disease. SHILAP Revista de lepidopterología. 1(4). 666–677. 2 indexed citations
6.
Lim, Albert Z., Daniel M. Jones, Matthew Bates, et al.. (2021). Risk of cardiac manifestations in adult mitochondrial disease caused by nuclear genetic defects. Open Heart. 8(1). e001510–e001510. 4 indexed citations
7.
Feeney, Catherine, Gráinne S. Gorman, Renae J. Stefanetti, et al.. (2020). Lower urinary tract dysfunction in adult patients with mitochondrial disease. Neurourology and Urodynamics. 39(8). 2253–2263. 5 indexed citations
8.
Feeney, Catherine, Evelyn Fagan, Alasdair Blain, et al.. (2019). A case‐comparison study of pregnant women with mitochondrial disease – what to expect?. BJOG An International Journal of Obstetrics & Gynaecology. 126(11). 1380–1389. 22 indexed citations
9.
Grady, John P., Sarah J. Pickett, Yi Shiau Ng, et al.. (2018). mt DNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease. EMBO Molecular Medicine. 10(6). 190 indexed citations
10.
Ng, Yi Shiau, Sarah J. Pickett, Andrew M. Schaefer, et al.. (2018). Height as a Clinical Biomarker of Disease Burden in Adult Mitochondrial Disease. The Journal of Clinical Endocrinology & Metabolism. 104(6). 2057–2066. 18 indexed citations
11.
Vincent, Amy E., Yi Shiau Ng, Kathryn White, et al.. (2016). The Spectrum of Mitochondrial Ultrastructural Defects in Mitochondrial Myopathy. Scientific Reports. 6(1). 30610–30610. 169 indexed citations
12.
Ng, Yi Shiau, Catherine Feeney, Andrew M. Schaefer, et al.. (2016). Pseudo‐obstruction, stroke, and mitochondrial dysfunction: A lethal combination. Annals of Neurology. 80(5). 686–692. 31 indexed citations
13.
Ng, Yi Shiau, Gráinne S. Gorman, Victoria Nesbitt, et al.. (2015). Phenotypes and Genotypes of Mitochondrial Disease- Findings from A National Mitochondrial Disease Cohort (P2.061). Neurology. 84(14_supplement). 1 indexed citations
14.
Gorman, Gráinne S., Andrew M. Schaefer, Yi Shiau Ng, et al.. (2015). Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Annals of Neurology. 77(5). 753–759. 643 indexed citations breakdown →
15.
Feeney, Catherine, et al.. (2015). Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Annals of Neurology 2015, 77(5), 753-759.. 2 indexed citations
16.
Nesbitt, Victoria, Charlotte L. Alston, Emma L. Blakely, et al.. (2014). A national perspective on prenatal testing for mitochondrial disease. European Journal of Human Genetics. 22(11). 1255–1259. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen Tuppen Breakdown of academic impact, for papers by L. He Breakdown of academic impact, for papers by Jyrki Kaukonen Breakdown of academic impact, for papers by M L Savontaus Breakdown of academic impact, for papers by Chun Shi Lin Breakdown of academic impact, for papers by Petri Luoma Breakdown of academic impact, for papers by Jirair K. Bedoyan Breakdown of academic impact, for papers by Paul J.M. Savelkoul Breakdown of academic impact, for papers by M. Pineda Breakdown of academic impact, for papers by Zarazuela Zolkipli‐Cunningham
Rankless by CCL
2026